1. Home
  2. ETO vs TBPH Comparison

ETO vs TBPH Comparison

Compare ETO & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETO
  • TBPH
  • Stock Information
  • Founded
  • ETO 2004
  • TBPH 2013
  • Country
  • ETO United States
  • TBPH United States
  • Employees
  • ETO N/A
  • TBPH N/A
  • Industry
  • ETO Investment Managers
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ETO Finance
  • TBPH Health Care
  • Exchange
  • ETO Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • ETO 387.3M
  • TBPH 464.5M
  • IPO Year
  • ETO N/A
  • TBPH N/A
  • Fundamental
  • Price
  • ETO $23.03
  • TBPH $9.30
  • Analyst Decision
  • ETO
  • TBPH Buy
  • Analyst Count
  • ETO 0
  • TBPH 3
  • Target Price
  • ETO N/A
  • TBPH $11.33
  • AVG Volume (30 Days)
  • ETO 26.5K
  • TBPH 224.8K
  • Earning Date
  • ETO 01-01-0001
  • TBPH 05-12-2025
  • Dividend Yield
  • ETO 6.67%
  • TBPH N/A
  • EPS Growth
  • ETO N/A
  • TBPH N/A
  • EPS
  • ETO N/A
  • TBPH N/A
  • Revenue
  • ETO N/A
  • TBPH $64,381,000.00
  • Revenue This Year
  • ETO N/A
  • TBPH $51.09
  • Revenue Next Year
  • ETO N/A
  • TBPH N/A
  • P/E Ratio
  • ETO N/A
  • TBPH N/A
  • Revenue Growth
  • ETO N/A
  • TBPH 12.12
  • 52 Week Low
  • ETO $19.85
  • TBPH $7.44
  • 52 Week High
  • ETO $25.21
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • ETO 43.17
  • TBPH 58.45
  • Support Level
  • ETO $22.36
  • TBPH $8.44
  • Resistance Level
  • ETO $23.69
  • TBPH $8.82
  • Average True Range (ATR)
  • ETO 0.94
  • TBPH 0.45
  • MACD
  • ETO 0.03
  • TBPH 0.08
  • Stochastic Oscillator
  • ETO 61.19
  • TBPH 94.70

About ETO Eaton Vance Tax-Advantage Global Dividend Opp

Eaton Vance Tax-advtgd Global Divid Oppo is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. The portfolio of investments consists of capital markets, chemicals, diversified, beverages, banks, electric utilities, oil, gas and consumable fuels, personal products, and other areas.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: